Filter Results:
(2,542)
Show Results For
- All HBS Web
(5,359)
- People (16)
- News (1,973)
- Research (2,542)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,903)
Show Results For
- All HBS Web
(5,359)
- People (16)
- News (1,973)
- Research (2,542)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,903)
Sort by
- 16 Feb 2016
- First Look
February 16, 2016
https://cb.hbsp.harvard.edu/cbmp/product/516027-PDF-ENG Harvard Business School Case 816-060 athenahealth's More Disruption Please Program No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816060-PDF-ENG Harvard Business School Case... View Details
Keywords: Sean Silverthorne
- 05 Nov 2001
- Research & Ideas
Venture Capital Goes Boomor Bust?
computer to access data stored on another and to interact with that information. As he publicized his innovation among his fellow employees and across the computing community, people admired the quality of his work. In fact, in... View Details
Keywords: by Paul A. Gompers & Josh Lerner
- 25 Jan 2011
- First Look
First Look: Jan. 25
Living Kidney Donation Authors:Ruthanne L. Hanto, Alvin E. Roth, M. Utku Ünver, and Francis L. Delmonico Publication:Chap. 8 in Kidney Transplantation: A Guide to the Care of Transplant Recipients, edited by D. McKay and S. Steinberg,... View Details
Keywords: Sean Silverthorne
- 06 Mar 2012
- First Look
First Look: March 6
(equipment or software, for example), and using these forms of capital more efficiently. Government spending for many public goods, such as education and infrastructure, contributes directly to one or more of them, whereas spending on View Details
Keywords: Sean Silverthorne
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- February 2019 (Revised August 2019)
- Case
Maccabitech: The Promise of Israel's Healthcare Data
By: Scott Duke Kominers and Carin-Isabel Knoop
Dr. Varda Shalev bridges technology and medicine through Maccabitech, a "research and innovation wing" of Israel's Maccabi Healthcare Services (MHS) that partners with research institutions, pharmaceutical companies, and startups. Shalev hopes to scale Maccabitech's... View Details
Keywords: Big Data; Healthcare; Analytics and Data Science; Digital Platforms; Health Care and Treatment; Innovation and Invention; Research; Entrepreneurship; Risk Management; Israel
Kominers, Scott Duke, and Carin-Isabel Knoop. "Maccabitech: The Promise of Israel's Healthcare Data." Harvard Business School Case 819-032, February 2019. (Revised August 2019.)
- February 2011 (Revised June 2011)
- Case
Hardina Smythe and the Healthcare Investment Conundrum
By: Matthew Rhodes-Kropf, Ann Leamon and Lisa Strope
Hardina Smythe, a recent MBA graduate, has just joined a top-tier venture capital firm in the difficult environment of late 2010. Her first assignment is to evaluate three different deals and make recommendations to the partners. Each potential investment has strengths... View Details
Keywords: Venture Capital; Asset Management; Private Equity; Entrepreneurship; Investment; Health Care and Treatment; Innovation and Invention; Financial Services Industry
Rhodes-Kropf, Matthew, Ann Leamon, and Lisa Strope. "Hardina Smythe and the Healthcare Investment Conundrum." Harvard Business School Case 811-073, February 2011. (Revised June 2011.)
- 05 Nov 2021
- Op-Ed
How to Tap the Talent Automated HR Platforms Miss
As the global staffing shortage grinds on, corporate recruiters everywhere are relying on their online hiring platforms and automated systems to deliver the candidates they need. Too often, these tools will fail them, sidelining many qualified workers in the process.... View Details
Keywords: by Joseph B. Fuller
- 25 Jul 2005
- Research & Ideas
An Organization Your Customers Understand
the role of organization in regard to a business unit's success, or in the choice of which structure to use, is intertwined with a large number of other important factors. These include the strategy of the business, the quality of its... View Details
Keywords: by Robert Simons
- 2024
- Working Paper
Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Fabio Villa
We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations
revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating
angina). Specifically, we chronicle the: 1) development of the... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Fabio Villa. "Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-010, July 2019. (Revised May 2024.)
- 15 Oct 2013
- First Look
First Look: October 15
governments holding a non-permanent seat on the United Nations Security Council or an Executive Directorship at the World Bank-are no more likely, on average, to get a negative quality rating than other projects. When aid is given to... View Details
Keywords: Sean Silverthorne
- 05 Mar 2019
- First Look
New Research and Ideas, March 5, 2019
lack prior ties to others at the bootcamp experience peer effects that influence the quality of their product prototypes. A one-standard-deviation increase in the performance of proximate teams is related to a two-thirds... View Details
Keywords: Dina Gerdeman
- 01 Sep 2015
- First Look
First Look -- September 1, 2015
these modalities. An incomplete understanding of the value of costly, yet effective, technologies could impede medical innovation and decrease the quality of cancer care through a reduction of patient access... View Details
Keywords: Sean Silverthorne
- 01 Apr 2008
- First Look
First Look: April 1, 2008
which, as the former parent of Delphi, has agreed to fund a portion of the massive pension and retiree health care liabilities that Delphi incurred when it separated from GM in a prior spin-off. The company... View Details
Keywords: Martha Lagace
- 22 Feb 2016
- Research & Ideas
The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist
Sawyer adds, “Gleason and others argued that their version of fair trade—albeit domestic oriented—offered higher wages, better services, and quality guarantees.” Prior to Gleason entering the scene, fair trade efforts had fallen flat.... View Details
- 22 Feb 2011
- Research & Ideas
The Most Important Management Trends of the (Still Young) Twenty-First Century
expertise will continue to be the bedrock of the academy but the boundaries that separate schools and faculties will melt away. This trend has already taken hold at Harvard, where faculty from across the University are building formal and informal networks around... View Details
Keywords: by Sean Silverthorne
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 08 Jul 2015
- What Do You Think?
Do Americans Work Too Much and Think About Work Too Little?
recognized Robert E. Downing's advice that we may need to define work before asking the question. For knowledge workers, "it is very difficult to determine when the workers are actually working Maybe we shouldn't be asking about hours (quantity) but instead... View Details
- 17 Feb 2003
- Research & Ideas
Building Communities as Well as Companies
explained, adding, "I also feel an overwhelming obligation to take good care of the money given to me by investors. The resources in this domain are so scarce—I want to succeed so more money will flow into the sector." "I... View Details
Keywords: by Julia Hanna